醫療保健合約研究組織 (CRO) 市場：按服務類型、最終用戶和地區分類

預計到 2026 年，醫療保健合約研究組織 (CRO) 市場規模將達到 1,990.4 億美元，到 2033 年將達到 5,392 億美元。預計從 2026 年到 2033 年，該市場將以 15.3% 的複合年成長率成長。

醫療保健領域的合約研究組織 (CRO) 受製藥和醫療設備業的委託，負責開發新藥和醫療設備。臨床試驗是藥物和醫療設備開發的關鍵環節，目前臨床試驗在不同地區的多個地點進行。預計在預測期內，藥物開發成本和時間的不斷增加將推動全球醫療保健 CRO 市場的成長。此外，主要藥物專利到期數量的增加預計也將促進市場成長。

市場動態

合作夥伴關係的增加推動了全球醫療保健行業合約研究市場的成長。例如，2022年9月，為全球提供端到端開發服務的醫療設備合約研究組織（CRO）北美科學協會（NAMSA）與頸動脈疾病和中風預防栓塞預防系統（EPS）的開發商InspireMD公司達成外包合作協議，旨在加速醫療設備的開發和商業化。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球醫療保健合約研究市場的主要參與者進行了分析：公司概況、財務表現、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
• 本研究涵蓋的主要公司包括 IQVIA Inc.、Covance Inc.（Labcorp 的子公司）、Pharmaceutical Product Development Inc.（Thermo Fisher Scientific Inc. 的子公司）、Parexel International (MA) Corporation、Charles River Laboratories、ICON plc、Medidata、Inventiv Health, Inc.（S.Ais Ltd. 的子公司）。
• 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球醫療保健合約研究市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過各種用於分析全球醫療保健合約研究市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期產品發布
• 流行病學
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析

第4章 全球醫療保健產業合約研究組織（CRO）市場：依服務類型分類，2021-2033年

• 臨床試驗
• 監管服務
• 醫用照明
• 臨床數據管理
• 其他

第5章 全球醫療保健產業合約研究組織（CRO）市場：依最終用戶分類，2021-2033年

• CROs
• 臨床試驗研究所
• AMCs

第6章 全球醫療保健產業合約研究組織（CRO）市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

• IQVIA Inc.
• Covance Inc（A subsidiary of Labcorp）
• Pharmaceutical Product Development Inc（A subsidiary of Thermo Fisher Scientific Inc.）
• Parexel International（MA）Corporation
• Charles River Laboratories
• ICON plc
• Medidata
• Inventiv Health, Inc.（A subsidiary of Syneos Health）
• Medpace
• Piramal Enterprises Ltd.

第8章

• 調查方法
• 關於本公司

Healthcare Contract Research Outsourcing Market is estimated to be valued at USD 199.04 Bn in 2026 and is expected to reach USD 539.20 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.3% from 2026 to 2033.

Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current scenario, clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development are expected to propel the global healthcare contract research outsourcing market growth over the forecast period. Furthermore, the increasing number of patent expirations of leading drugs is also expected to aid in the growth of the market.

Market Dynamics

Increasing incidences of collaborations and partnerships are attributed to the growth of the global healthcare contract research outsourcing market. For instance, in September 2022, North American Science Associates, LLC (NAMSA), a Medical Devices Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc., a developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease and prevention of strokes, entered an outsourcing partnership to accelerate medical device development and commercialization.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global healthcare contract research outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• The key companies covered as a part of this study include, IQVIA Inc., Covance Inc (a subsidiary of Labcorp), Pharmaceutical Product Development Inc (a subsidiary of Thermo Fisher Scientific Inc), Parexel International (MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. (A subsidiary of Syneos Health), Medpace, and Piramal Enterprises Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global healthcare contract research outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare contract research outsourcing market.

Market Segmentation

• Global Healthcare Contract Research Outsourcing Market, By Services Type (Revenue, USD Bn, 2021 - 2033)
• Clinical Trials
  • Drug Discovery
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Regulatory Services
  • Medical Writing
  • Clinical Data Management
  • Others
• Global Healthcare Contract Research Outsourcing Market, By End User (Revenue, USD Bn, 2021 - 2033)
• CROs
• Clinical Trial Laboratories
• AMCs
• Global Healthcare Contract Research Outsourcing Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
• IQVIA Inc.
• Covance Inc (A subsidiary of Labcorp)
• Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
• Parexel International (MA) Corporation
• Charles River Laboratories
• ICON plc
• Medidata
• Inventiv Health, Inc. (A subsidiary of Syneos Health)
• Medpace
• Piramal Enterprises Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Services Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Healthcare Contract Research Outsourcing Market, By Service Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Clinical Trials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Drug Discovery
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
• Regulatory Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Medical Writing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Clinical Data Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Healthcare Contract Research Outsourcing Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• CROs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Clinical Trial Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• AMCs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Healthcare Contract Research Outsourcing Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• IQVIA Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Covance Inc (A subsidiary of Labcorp)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Parexel International (MA) Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ICON plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medidata
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Inventiv Health, Inc. (A subsidiary of Syneos Health)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medpace
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Piramal Enterprises Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us